Affymetrix Aims to Diversify Revenue Stream With Upcoming DMET Service, Navigenics Pact | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
With the market for DNA gene expression research waning, Affymetrix is broadening its services offerings to include drug metabolism testing in the short term and personal genetics in the longer term through a collaboration with consumer genotyping startup Navigenics.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.